Related references
Note: Only part of the references are listed.Serum Mannan-Binding Lectin in Egyptian Patients With Chronic Hepatitis C: Its Relation to Disease Progression and Response to Treatment
Serag Esmat et al.
Hepatitis Monthly (2012)
L-Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in vitro and in vivo
Qin Pan et al.
JOURNAL OF INNATE IMMUNITY (2012)
Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal Antibodies
Masanori Terajima et al.
JOURNAL OF VIROLOGY (2011)
Ficolin-2 Levels and FCN2 Haplotypes Influence Hepatitis B Infection Outcome in Vietnamese Patients
Hoang V. Tong et al.
PLOS ONE (2011)
Complement and its role in innate and adaptive immune responses
Jason R. Dunkelberger et al.
CELL RESEARCH (2010)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation
Jun Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Significance of Anti-HCV Signal-to-Cutoff Ratio in Predicting Hepatitis C Viremia
Yeon Seok Seo et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2009)
Ficolins: Novel pattern recognition molecules of the innate immune response
Valeria L. Runza et al.
IMMUNOBIOLOGY (2008)
Recognition of acetylated oligosaccharides by human L-ficolin
Anders Krarup et al.
IMMUNOLOGY LETTERS (2008)
Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns
Tina Hummelshoj et al.
MOLECULAR IMMUNOLOGY (2008)
Complement deficiencies and systemic lupus erythematosus
Lennart Truedsson et al.
AUTOIMMUNITY (2007)
Human α-defensins block papillomavirus infection
CB Buck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Treating viral hepatitis C: Efficacy, side effects, and complications
M. P. Manns et al.
GUT (2006)
Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria
AM Nahid et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2006)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins
E Leikina et al.
NATURE IMMUNOLOGY (2005)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld et al.
NATURE (2005)
Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2
T Hummelshoj et al.
HUMAN MOLECULAR GENETICS (2005)
Hepatitis C virus genotype distribution in China: Predominance of closely related subtype 1b isolates and existence of new genotype 6 variants
L Lu et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin
A Krarup et al.
INFECTION AND IMMUNITY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1
D Candotti et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Outcomes of interferon alpha and ribavirin treatment for chronic hepatitis C in patients with normal serum aminotransaminases
CK Hui et al.
GUT (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Share Paper
